In the 41-patient REDWOOD-HCM trial, myosin inhibitor CK-274 achieved statistically significant improvements in blood flow reaching the normal range in 13 out of 14 patients with obstructive HCM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback